A new national study confirms what Portland Medicare patients have long complained about, and the numbers are worse than most ...
In the global fight against HIV/Aids, one of the most exciting innovations is not a new drug, but a better filing system. This is what we’re seeing in Malawi, one of the most HIV-affected countries in ...
EO Care, Inc., a leading provider of clinically guided cannabinoid-based symptom management, today announced the appointment ...
Verve Medical, the leader in non?invasive renal pelvic denervation (RPD) technology, today announced successful treatment of the first patient in its randomized, double?blinded U.S. pilot clinical ...
Year to Record $14.5 Million Q4 Operating Income of $1.9 Million; Adjusted EBITDA Increased by 53% to $2.3 Million, Reflecting Significant Operating Leverage Full Year 2025 Revenue Increased by ...
A woman suffered "avoidable" sight loss after waiting two years for NHS cataract surgery in Wales. The woman endured 11 cancelled apppointments and failures in the management of her care during the ...
South African Official News on MSN
'Fiscal discipline non-negotiable': Maile tables Gauteng budget
'Fiscal discipline non-negotiable': Maile tables Gauteng budget Gauteng MEC for Finance and Economic Development Lebogang Maile has tabled a R179.2 billion budget for the 2026/27 financial year aimed ...
Earnings call Exagen reported Q4 2025 revenue of $66.6M, up nearly 20% YoY, with test volume growth of 11% and ASP up 7%. Management guided 2026 revenue to $70M–$73M, expecting continued volume and ...
Persistence Market Research, a leading management consulting firm, has released this update on the 3D printed clear dental aligners market. These innovative ...
Montgomery County resident Sandra Blue was the lucky recipient of one of three iPad minis recently given away by the Sandhill Regional Library System for her participation in the library services ...
CAMBRIDGE, Mass. and HOUSTON, March 11, 2026 /PRNewswire/ — Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVs™), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results